Study shows targeting DDX3 with RK-33 reduced the viral load

A new study has focused on developing a novel anti-SARS-CoV-2 therapy using HTA directed against the human host DEAD-box RNA helicase.

Related Keywords

, Drug Administration , Respiratory Syncytial , West Nile , Components Analysis , Coronavirus Disease Covid 19 , Cars , Ars Cov 2 , Compound , Coronavirus , Covid 19 , Wood , Enome , Enomic , Helicase , Olecule , Pandemic , Protein , Espiratory , Na , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Spike Protein , Yndrome , Translation , Vaccine , Virus ,